Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
about
An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsInduced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsHuman-induced pluripotent stem cell models of inherited cardiomyopathiesA Systemized Approach to Investigate Ca(2+) Synchronization in Clusters of Human Induced Pluripotent Stem-Cell Derived CardiomyocytesTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineRecent advances in animal and human pluripotent stem cell modeling of cardiac laminopathyhiPSC Modeling of Inherited CardiomyopathiesModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesSelumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK PathwayHuman stem cells for modeling heart disease and for drug discovery.Cellular mechanosensing: getting to the nucleus of it all.Deleterious assembly of the lamin A/C mutant p.S143P causes ER stress in familial dilated cardiomyopathy.Progeroid laminopathy with restrictive dermopathy-like features caused by an isodisomic LMNA mutation p.R435C.Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes.Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols.Induced pluripotent stem cells: at the heart of cardiovascular precision medicine.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Disease modelling using human iPSCs.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.Current insights into LMNA cardiomyopathies: Existing models and missing LINCsHuman heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes.ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features.An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells.Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.Genetic Mechanisms Contribute to the Development of Heart Failure in Patients with Atrioventricular Block and Right Ventricular Apical PacingHuman pluripotent stem cell models of cardiac disease: from mechanisms to therapies.Connecting Sarcomere Protein Mutations to Pathogenesis in Cardiomyopathies: The Development of "Disease in a Dish" ModelsA novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females.Linker of nucleoskeleton and cytoskeleton complex proteins in cardiomyopathyModeling Skeletal Muscle Laminopathies Using Human Induced Pluripotent Stem Cells Carrying Pathogenic Mutations
P2860
Q26775122-B6A284BC-7CDD-4625-B820-28E84E173F39Q26781825-E569FC93-3915-4C4A-9373-412BEBFD3A09Q26798131-3B6D4CB6-464F-4777-BA09-3CFACFA3D8DAQ26852052-A7F9F7C8-17CD-4FDD-A008-9A8F9F5A68E5Q27330969-6B7EA1FD-318D-4310-8AF6-2E6C55361D0AQ28076397-9FAAFC2D-AD4F-4543-BCE6-1290DCB312B4Q28077171-1DAD5F9E-EF62-47B0-BE69-A1EE41C0220BQ28240320-4B6B62EC-21ED-47AD-BA9C-1C31436E2393Q28255887-2936C097-BC7A-4D7F-B4B9-26FD36570A75Q28552721-4B64D817-A2A6-4B39-B357-ECF334B4B2FFQ34433363-05CAA0AF-AACC-4ACF-B183-2A67DF381289Q34614178-15C3F34D-2FC1-4337-B1E5-95A189AC9B19Q37120369-2E003762-0910-41C9-8A2F-96484EB8AB21Q37298891-91903403-7658-4476-8EF0-ADD4459CD8D7Q38393181-3F3E328D-5EE9-4808-9EC8-4F4C9563CF33Q38454536-96BC069C-8DD5-44B1-8456-C9AB35753FA2Q38530607-1CF91E3F-DDB0-465F-A460-978FFD3F5E94Q38740489-8CB1F462-067A-40F2-B05B-544688717A4EQ38786687-7DFA85A0-A99F-40CC-B487-5CF899B841BAQ38874111-FA70A0D1-AA53-41FF-B2BC-6F5F5E91BCD9Q38919220-970B8A72-A1E2-482D-A214-0E2BA071A346Q39010745-ABBA6475-8129-44BE-8404-7C37BB499FB1Q39050993-5B090CE3-A3D1-484B-9674-37A3200ACC85Q39104972-C181F2D7-5CCF-430F-BCCD-C67BEA3CC980Q39345477-95D0F936-CE32-44D7-87C0-CC3E4C5C19FAQ39384466-47DB10A1-5F72-4A45-BA8D-A8EFFAE91F87Q40634162-B036848F-BF5E-44E1-AEB7-6B369995D8A9Q41628207-BE03187E-C23E-4466-BEB0-411B328F041DQ41633912-6C7211E9-4183-46A9-A2FA-955675E68F22Q41664792-2BAEE732-D3BF-4B68-80AB-C838F43A7279Q42364992-59F480A6-49B3-4EAC-ADE6-D2B8C6D13EB0Q50884552-512E025A-B8F7-4E81-93AF-38289E33743EQ57171613-E9E52DE9-AA4D-4E53-8379-0884DF744133Q58562640-AB1144B5-2043-416D-9047-EE861D025566
P2860
Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Modeling of lamin A/C mutation ...... nduced pluripotent stem cells.
@ast
Modeling of lamin A/C mutation ...... nduced pluripotent stem cells.
@en
type
label
Modeling of lamin A/C mutation ...... nduced pluripotent stem cells.
@ast
Modeling of lamin A/C mutation ...... nduced pluripotent stem cells.
@en
prefLabel
Modeling of lamin A/C mutation ...... nduced pluripotent stem cells.
@ast
Modeling of lamin A/C mutation ...... nduced pluripotent stem cells.
@en
P2093
P2860
P356
P1433
P1476
Modeling of lamin A/C mutation ...... nduced pluripotent stem cells.
@en
P2093
Alan Colman
Chung-Wah Siu
Hung-Fat Tse
Jenny Chung-Yee Ho
Jinqiu Zhang
Ka-Wing Au
Kenneth Weijian Lay
Kwong-Man Ng
Lai-Yung Wong
Wing-Hon Lai
P2860
P304
P356
10.18632/AGING.100503
P577
2012-11-01T00:00:00Z